June 9, 2016 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: BLVKF) (the “Company”) announced today that it has been selected by a major hospital group in the southwest U.S. as an approved vendor.  This decision will add six new hospitals to the list of facilities currently utilizing the Company’s high quality allograft […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone